DLD Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-54,500
Closed -$1.58M 100
2019
Q1
$1.58M Sell
54,500
-607,000
-92% -$15.7M 0.06% 78
2018
Q4
$8.67M Buy
661,500
+85,400
+15% +$1.36M 0.59% 36
2018
Q3
$11.6M Sell
576,100
-6,900
-1% -$156K 0.58% 45
2018
Q2
$13.8M Buy
583,000
+473,000
+430% +$12.2M 1.04% 27
2018
Q1
$2.48M Buy
+110,000
New +$2.89M 0.22% 63
2017
Q4
Sell
-376,700
Closed -$11.8M 91
2017
Q3
$11.8M Buy
376,700
+81,700
+28% +$1.56M 1.16% 21
2017
Q2
$5.06M Sell
295,000
-35,400
-11% -$605K 0.66% 26
2017
Q1
$5.78M Buy
+330,400
New +$5.1M 0.93% 21

Other funds holding INSM

DLD Asset Management's INSM Position: Q4 2017 in Review

DLD Asset Management sold out of Insmed (INSM) in Q4 2017, closing a stake of 240,600 shares — an estimated $7.51M sold.

DLD Asset Management first reported a position in INSM in Q2 2017 and held it in 2 quarters. The position peaked at $7.51M in Q3 2017. 129 funds tracked by Wall St. Rank hold INSM as of Q4 2017.

  • DLD Asset Management reported no remaining Insmed position as of Q4 2017 after selling out during the quarter.
  • DLD Asset Management sold 240,600 Insmed shares in Q4 2017, an estimated $7.51M.
  • DLD Asset Management first reported a position in Insmed in Q2 2017 and held it in 2 quarters.
  • DLD Asset Management's Insmed position peaked at $7.51M in Q3 2017.
  • 129 funds tracked by Wall St. Rank held Insmed as of Q4 2017.

Based on DLD Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.